Exhibit 2. Adjusted prescription rates for patients with new onset of type 2 diabetes, hyperlipidemia, or hypertension by team-based care and provider type, 2013–2018.

Source: Authors’ analysis of de-identified electronic health record data from 2013 to 2018 for adults with a new chronic disease as identified by an abnormal biomarker (N = 22,874 for type 2 diabetes, N = 24,510 for hyperlipidemia, and N = 28,078 for hypertension).

Notes: Colored bars indicate the predicted values from a regression of an indicator for a patient receiving at least two disease-appropriate prescription orders (including refills) within one year on provider, including organization fixed effects as well as patient and disease severity covariates as described in the text. Error bars represent 95% confidence intervals. p-values for team total vs. solo total were as follows: diabetes, <0.001; hyperlipidemia, <0.001; hypertension, <0.001. Non-physician providers are physician assistants and nurse practitioners. A mixed team is composed of both physician and non-physician providers.